4.8 Editorial Material

Beyond viral dependence: The pathological consequences of HCV-induced EGF signaling

期刊

JOURNAL OF HEPATOLOGY
卷 69, 期 3, 页码 564-566

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2018.04.005

关键词

-

资金

  1. European Union Horizon 2020 research and innovation program (ERC AdG HEPCIR) [667273]
  2. European Union Horizon 2020 research and innovation program (H2020 HEP-CAR) [667273]
  3. European Union Horizon 2020 research and innovation program (ERC POC PRELICAN) [755460]
  4. NCI of the National Institutes of Health [1R21CA209940-01A1]
  5. French National Research Agency [LABEX ANR-10-LABX-0028 HEPSYS]
  6. Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-1-0363]
  7. French Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS) [ECTZ4236, ECTZ4446]
  8. European Research Council (ERC) [755460] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Gastroenterology & Hepatology

We can and should do better-an interview with the 2020 Nobel prize laureates who revolutionized hepatology

Thomas F. Baumert

JOURNAL OF HEPATOLOGY (2021)

Editorial Material Medicine, General & Internal

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges

Joachim Lupberger, Thomas F. Baumert

JOURNAL OF CLINICAL MEDICINE (2022)

Article Microbiology

GOLT1B Activation in Hepatitis C Virus-Infected Hepatocytes Links ER Trafficking and Viral Replication

Jacqueline Butterworth, Damien Gregoire, Marion Peter, Armando Andres Roca Suarez, Guillaume Desandre, Yannick Simonin, Alessia Virzi, Amal Zine El Aabidine, Marine Guivarch, Jean-Christophe Andrau, Edouard Bertrand, Eric Assenat, Joachim Lupberger, Urszula Hibner

Summary: Chronic hepatitis C infection is associated with altered gene expression profiles, which increases the risk of hepatocellular carcinoma. A novel HCV target gene, GOLT1B, has been identified, and its expression is correlated with poor outcome in HCC.

PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences

Zakaria Boulahtouf, Alessia Virzi, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger

Summary: Chronic viral hepatitis is a major cause of liver disease and hepatocellular carcinoma. Despite being caused by different viruses, hepatitis B, C, and D have striking similarities in pathological impact. The advancements in omics and bioinformatics have revealed the important role of signaling networks in viral pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Virology

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

Andrea Magri, James M. Harris, Valentina D'Arienzo, Rosalba Minisini, Frank Juhling, Peter A. C. Wing, Rachele Rapetti, Monica Leutner, Barbara Testoni, Thomas F. Baumert, Fabien Zoulim, Peter Balfe, Mario Pirisi, Jane A. McKeating

Summary: Chronic hepatitis B virus (HBV) infection is a global health problem that is characterized by interactions between the virus and the host immune system, leading to a spectrum of liver disease. The study investigates the contribution of HBV genomes, including episomal covalently closed circular DNA (cccDNA) and chromosomal integrants, to viral transcripts in chronic hepatitis B (CHB). The results demonstrate that cccDNA-derived transcripts are associated with liver inflammation markers, while integrant-derived transcripts are significantly associated with increasing age but not with inflammatory status.

VIRUSES-BASEL (2022)

Review Medicine, General & Internal

Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Valerio Taverniti, Gaetan Ligat, Yannick Debing, Dieudonne Buh Kum, Thomas F. Baumert, Eloi R. Verrier

Summary: Despite the availability of a preventive vaccine, over 250 million people are still affected by chronic hepatitis B virus (HBV) infection, which is a major cause of liver disease and hepatocellular carcinoma. The core protein of HBV plays a crucial role in the virus's life cycle and represents a promising target for the development of new antiviral therapies. Capsid assembly modulators (CAM) have shown potent antiviral activity in cell-based and in vivo models, and several CAMs are currently being developed for clinical use.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Gastroenterology & Hepatology

The scientific basis of combination therapy for chronic hepatitis B functional cure

Seng Gee Lim, Thomas F. Baumert, Carolina Boni, Ed Gane, Massimo Levrero, Anna S. Lok, Mala K. Maini, Norah A. Terrault, Fabien Zoulim

Summary: Functional cure of chronic hepatitis B (CHB), achieved through hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy, is the goal of current treatment. However, the rarity of achieving this cure with current therapy highlights the need for novel approaches. The three categories of treatment include reducing viral replication, reducing antigen load, and immunotherapies. Combination therapy of nucleos(t)ide analogues and immunotherapy shows promise in reducing HBsAg levels and inducing HBsAg loss in some patients, particularly those with low baseline HBsAg levels. Monitoring during therapy using viral and immunological biomarkers is important to predict HBsAg loss and understand its mechanisms.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Cell Biology

Tight Junction Protein Signaling and Cancer Biology

Zeina Nehme, Natascha Roehlen, Punita Dhawan, Thomas F. F. Baumert

Summary: Tight junctions (TJs) are intercellular protein complexes that control paracellular permeability and cell polarity, and recent studies have shown their functional role beyond these classic functions. TJ proteins play crucial roles in cancer pathogenesis by modulating key signaling pathways that regulate cell proliferation, migration, and differentiation, as well as promoting stem cell phenotypes in cancer cells. Additionally, TJ proteins have been used as therapeutic targets and prognostic markers in preclinical and clinical studies. This review summarizes the functional role of TJ proteins in cancer biology and their potential for novel cancer prevention and treatment strategies.
Editorial Material Gastroenterology & Hepatology

Unfolding the mechanism of hepatocyte injury of HBV precore and core promoter variants

Nikolaus Jilg, Thomas F. Baumert

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation

Dieudonne Buh Kum, Hannah Vanrusselt, Abel Acosta Sanchez, Valerio Taverniti, Eloi R. Verrier, Thomas F. Baumert, Cheng Liu, Jerome Deval, Nikky Corthout, Sebastian Munck, Leonid Beigelman, Lawrence M. Blatt, Julian A. Symons, Pierre Raboisson, Andreas Jekle, Sandrine Vendeville, Yannick Debing

Summary: This study uncovers a novel mechanism of action for CAM-As in the treatment of chronic hepatitis B, where HBc aggregation induces cell death, leading to hepatocyte proliferation and loss of covalently closed circular DNA or its equivalent, possibly assisted by an induced innate immune response.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Evaluation of the HBV liver reservoir with fine needle aspirates

Barbara Testoni, Armando Andres Roca Suarez, Arianna Battisti, Marie-Laure Plissonnier, Marintha Heil, Thierry Fontanges, Francois Villeret, Yasmina Chouik, Massimo Levrero, Upkar Gill, Patrick Kennedy, Fabien Zoulim

Summary: This study validated the possibility to quantify cccDNA and assess its transcriptional activity in patients with chronic hepatitis B by combining FNA and droplet digital PCR. The use of FNA in clinical trials to evaluate the intrahepatic viral reservoir during the development of new antivirals and immunomodulatory agents is supported.

JHEP REPORTS (2023)

Meeting Abstract Gastroenterology & Hepatology

A humanized Claudin-1 specific monoclonal antibody for treatment of hepatocellular carcinoma

Natascha Roehlen, Sara Cherradi, Marion Muller, Nuno Almeida, Francois H. T. Duong, Emilie Crouchet, Frank Juhling, Houssein El Saghire, Sarah Durand, Clara Ponsolles, Marine Oudot, Antonio Saviano, Emanuele Felli, Patrick Pessaux, Gerhard Christofori, Joachim Lupberger, Greg Elson, Markus Meyer, Roberto Iacone, Tamas Schweighoffer, Patrice Laquerriere, Catherine Schuster, Laurent Mailly, Thomas Baumert

JOURNAL OF HEPATOLOGY (2021)

暂无数据